Rapid risk assessment: Potential contamination of Viaspan® organ perfusion solution
An organ perfusion solution known as Viaspan® has been identified as being potentially contaminated with Bacillus cereus. Viaspan®, which is used to preserve organs prior to transplantation, is distributed to a number of countries around the world.According to ECDC's risk assessment, the likelihood of contamination and risk of infection in recipients or potential recipients of organ transplants preserved in Viaspan® solution produced after July 2011 appears to be low, based on the negative results of microbiological cultures in solution samples and the absence of reported patient cases to date. Nevertheless, vigilance is recommended to mitigate the risk.
Rapid risk assessment: Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update
10 Jun 2021 - This report assesses SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA.
Threat Assessment Brief: Emergence of SARS-CoV-2 B.1.617 variants in India and situation in the EU/EEA
11 May 2021 - The aim of this Threat Assessment Brief is to assess potential public health implications of B.1.617 variants for EU/EEA countries, with a focus on lineage B.1.617.2. On 24 May, ECDC upgraded B.1.617.2 to a variant of concern, after new information became available on increased transmissibility and some impact on vaccine effectiveness, especially after one vaccine dose. The suggestions highlighted in the Threat Assessment Brief regarding options for response remain valid, particularly vaccination rollout as a high priority to reduce COVID-19 mortality by vaccinating those at risk of severe illness in the shortest time possible.
Threat Assessment Brief: Dengue epidemic in Réunion, 2021
5 May 2021 - This document assesses the risk related to dengue for EU/EEA citizens travelling to or residing in Réunion, and the risk related to having an outbreak of dengue in mainland EU/EEA following introduction of the virus from Réunion.